Charles River Laboratories International (CRL) Depreciation and Depletion (2011 - 2025)

Charles River Laboratories International's Depreciation and Depletion history runs 15 years deep, the most recent figure standing at $45.1 million for Q4 2025.

• In Q4 2025, Depreciation and Depletion fell 6.82% year-over-year to $45.1 million; the TTM figure through Dec 2025 stood at $177.6 million (down 6.62% YoY), while the FY2025 annual figure was $177.6 million, down 6.62% from the prior year.
• Depreciation and Depletion for Q4 2025 stood at $45.1 million, up from $44.8 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $155.6 million in Q4 2022, with the low at $559000.0 in Q1 2022.
• The 5-year median for Depreciation and Depletion is $44.4 million (2023), against an average of $42.1 million.
• Peak annual rise in Depreciation and Depletion reached 7878.53% in 2023, while the deepest fall reached 70.12% in 2023.
• Charles River Laboratories International's Depreciation and Depletion stood at $138.6 million in 2021, then gained by 12.28% to $155.6 million in 2022, then sank by 70.12% to $46.5 million in 2023, then increased by 4.09% to $48.4 million in 2024, then declined by 6.82% to $45.1 million in 2025.
• Business Quant data shows CRL's Depreciation and Depletion at $45.1 million in Q4 2025, $44.8 million in Q3 2025, and $44.3 million in Q2 2025.